Recent insider selling at Avnet, especially at prices below current share price, signals negativity. The absence of insider buying in the past year and low insider ownership suggest a misalignment between management and smaller shareholders, making us wary of the stock.
Despite Avnet's current undervaluation, the negative profit outlook introduces a high level of uncertainty and risk. Investors are advised to consider these factors before deciding to increase their portfolio exposure to Avnet or diversify into another stock.
Given Avnet's bleak earnings forecast, its low P/E ratio appears justified as the potential for earnings improvement is not viewed by investors as strong enough to demand a higher ratio. Without better conditions, there might be obstacles to share price growth.
Insider selling at Avnet without recent insider buying could be worrying for potential investors. Investigate carefully as earnings grow, but lacking substantial ownership and demonstrating insider selling.
Avnet's cheaper price could allure investors, but the negative profit outlook and high beta escalates the investment risk. Its high future uncertainty raises the stakes of the investment.
TeslaSmurf
:
UPGRADING Twitter ? With tons of bots and malfunction ? With decreasing profits (already very low) and the FALSE declaration in the SEC filing ? They may want to pump it a little higher, then sell it…
Avnet Stock Forum
• $Advanced Micro Devices (AMD.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $115 (from $100)
• $Amphenol (APH.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $83
• $CDW Corp (CDW.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $200 (from $205)
• $Costco (COST.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $579 (from $525)
• $New Oriental (EDU.US)$ : CICC Upgrades to Outperform from M...
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $Gol Intelligent Airlines (GOL.US)$ +18.5% (earnings report)
• $LendingClub (LC.US)$ +16.9% (earnings report)
• $MaxLinear (MXL.US)$ +15.9% (earnings report)
• $Meta Platforms (FB.US)$ +15.8% (Facebook revenue slows but user gains boost stock)
• $Noodles & Co (NDLS.US)$ +15.2% (earnings report)
• $Avnet (AVT.US)$ +11.2% (earnings report)
• $Qualcomm (QCOM.US)$ +6.8% (Qualcomm reports earnings as smartphone market weakens)
• $Vale SA (VALE.US)$ +5.3% (an...
No comment yet